Sheng-Min Wang
Overview
Explore the profile of Sheng-Min Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
937
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Wang S, Kang D, Kim S, Lim H, Um Y
Psychiatry Investig
. 2025 Feb;
22(2):218-220.
PMID: 40017286
No abstract available.
2.
Byeon G, Kang D, Kim Y, Kim G, Kim K, Kim H, et al.
Dement Neurocogn Disord
. 2025 Feb;
24(1):24-43.
PMID: 39944528
Background And Purpose: Dementia often accompanies behavioral and psychological symptoms of dementia (BPSD), including agitation, aggression, depression, and psychosis, which impact patients' quality of life and caregiver burden. Effective management...
3.
Kim Y, Kang D, Kim G, Kim K, Kim H, Na S, et al.
Dement Neurocogn Disord
. 2025 Feb;
24(1):1-23.
PMID: 39944527
Background And Purpose: This clinical practice guideline provides evidence-based recommendations for treatment of dementia, focusing on cholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists for Alzheimer's disease (AD) and other types...
4.
Wang S, Jung Y, Han K, Ohn K, Park H, Park C, et al.
Heliyon
. 2025 Jan;
11(1):e40617.
PMID: 39758387
Purpose: We aimed to investigate the risk of developing depression in individuals with primary open-angle glaucoma with associated vision impairment. Methods: We conducted a nationwide, population-based cohort study using data...
5.
Choi W, Wang S, Woo Y, Bahk W
J Clin Psychiatry
. 2024 Dec;
86(1).
PMID: 39724018
Pharmacotherapy plays a crucial role in treating attention-deficit/ hyperactivity disorder (ADHD). However, current medications for ADHD have limitations and potential adverse effects. Glutamate, a neurotransmitter that directly and indirectly modulates...
6.
Lee J, Kim M, Kim H, Kim S, Um Y, Wang S, et al.
Front Aging Neurosci
. 2024 Sep;
16:1410185.
PMID: 39286460
Background: The interrelation between infections, subjective cognitive decline (SCD), and dementia development is recognized, but not fully understood. This study explored the combined effect of specific infections and SCD on...
7.
Ha J, Choi S, Moon S, Han J, Lee J, Park S, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Sep;
25(1):e40-e49.
PMID: 39242305
Background: Dementia, a growing global health issue, affects older adults and specific groups like long-term cancer survivors. The link between cancer survival and dementia is debated. Multiple myeloma (MM), a...
8.
Kang D, Wang S, Um Y, Kim S, Kim T, Kim D, et al.
Front Psychiatry
. 2024 Sep;
15:1428535.
PMID: 39224475
Background: Alzheimer's disease (AD) encompasses a spectrum that may progress from mild cognitive impairment (MCI) to full dementia, characterized by amyloid-beta and tau accumulation. Transcranial direct current stimulation (tDCS) is...
9.
Yang K, Kim S, Yang H, Wang S, Jeong B, Lim H, et al.
Clin Mol Hepatol
. 2024 Aug;
30(4):929-942.
PMID: 39188230
Background/aims: Alcohol-associated liver disease (ALD) is a public health concern. ALD patients often have psychiatric comorbidities, but the effects of psychiatric interventions on ALD are not well-established. This study explores...
10.
Kang D, Wang S, Um Y, Kim S, Kim T, Kim D, et al.
Sci Rep
. 2024 Aug;
14(1):18818.
PMID: 39138281
Despite the growing interest in precision medicine-based therapies for Alzheimer's disease (AD), little research has been conducted on how individual AD risk factors influence changes in cognitive function following transcranial...